Skip to main content
Equibles

BARCLAYS PLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,223
+$28,886 QoQ
Shares Held
4,724
+42.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. RNAC ranks #277 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in RNAC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,223 4,724
2026-03-31 $20,337 3,307
2025-12-31 $127,263 17,651
2025-09-30 $182,345 17,842
2025-06-30 $318,713 30,675
2025-03-31 $189,383 14,369
2024-12-31 $342,063 19,099
2024-09-30 $187,169 11,611
2024-06-30 $101,611 3,762
2024-03-31 $77,319 118,953
2023-12-31 $137,917 200,171
2023-09-30 $63,244 59,665
2023-06-30 $68,588 61,240
2023-03-31 $52,819 38,000
2022-12-31 $42,939 38,000
2022-09-30 $64,219 39,158
2022-06-30 $54,388 41,518
2022-03-31 $69,998 56,909
2021-12-31 $364,236 111,729
2021-09-30 $154,385 37,112
2021-06-30 $121,549 29,079
2021-03-31 $308,676 68,216
2020-12-31 $178,772 59,001
2020-09-30 $189,543 76,429
2020-06-30 $211,130 74,342
2020-03-31 $89,432 37,109